Human services

Partnership for a Drug-Free New Jersey’s Opioid Prevention Initiatives Recognized at National Rx Summit

Retrieved on: 
Thursday, April 4, 2024
Prohibition, Mental health, Organization, Communication, Partnership, COVID-19, Patient, Knowledge, Human services, Volunteering, Advertising, Substance use disorder, Addiction, Poster, Government, Knockout, Cryptocurrency

PDFNJ highlighted these initiatives, which are critical in providing New Jersey communities with vital information on preventing opioid misuse, as part of the Rx Summit’s poster sessions.

Key Points: 
  • PDFNJ highlighted these initiatives, which are critical in providing New Jersey communities with vital information on preventing opioid misuse, as part of the Rx Summit’s poster sessions.
  • Through this program, more than 10,000 volunteers throughout the state share opioid prevention and awareness messages and materials.
  • “At the Rx Summit, we shared our strategies for reaching New Jersey communities with essential information on preventing opioid misuse,” said Angelo Valente, Executive Director of PDFNJ.
  • Since its inception, the Partnership has garnered 226 advertising and public relations awards from national, regional and statewide media organizations.

Civitas Networks for Health to Host 2024 Annual Conference in Detroit This October

Retrieved on: 
Thursday, March 28, 2024
Organization, IHS, Conference, Health equity, Partnership, CRISP, Wayne State University, Public, Human services, Indian Health Service, Phoenix Project, Civitas, HIE, Nursing

WASHINGTON, March 28, 2024 (GLOBE NEWSWIRE) -- Civitas Networks for Health today announced its 2024 Annual Conference will take place Tuesday, October 15 through Thursday, October 17, 2024, in Detroit, Michigan.

Key Points: 
  • WASHINGTON, March 28, 2024 (GLOBE NEWSWIRE) -- Civitas Networks for Health today announced its 2024 Annual Conference will take place Tuesday, October 15 through Thursday, October 17, 2024, in Detroit, Michigan.
  • "We are thrilled to host the 2024 Civitas Annual Conference in Detroit, a city known for its resilience and innovation,” said Lisa Bari, CEO, Civitas Networks for Health.
  • Civitas’ Host Committee includes the following member organizations: Blue Cross Blue Shield Association , Health Impact Ohio , Illinois Public Health Institute , Indiana Health Information Exchange , MetaStar , Michigan Health Information Network , Michigan Multipayer Initiatives , Michigan Public Health Institute , Ohio Health Information Partnership , PHOENIX Project – Wayne State University , The Health Collaborative , Velatura HIE Corporation , Wisconsin Collaborative for Healthcare Quality , and Wisconsin Statewide Health Information Network .
  • The conference agenda will feature expert keynote speakers, each offering unique insights on turning health data into meaningful health care outcomes.

Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego

Retrieved on: 
Thursday, March 28, 2024
MEG, Development, Psychiatry, Veteran, Physician, Post-traumatic stress disorder, NSI, Analysis of variance, Patient, UC, RPQ, Jesse Russell, Radiology, Human services, PCS, Concussion, Trial of the century, University, McGill Pain Questionnaire, Brain damage, Pain, ANOVA, Vaccine, PTSD, MPQ, Medical imaging

HOUSTON, TEXAS, March 28, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced the positive results of a clinical study evaluating Nexalin’s Gen-2 tACS device for reducing pain in veteran patients with Mild Traumatic Brain Injury (mTBI). The study was conducted at The University of California, San Diego, and is further detailed in an abstract co-authored by the United States Department of Veterans Affairs (VA) San Diego Healthcare System, and the Radiology, Psychiatry and Neurosciences Departments of UC San Deigo.

Key Points: 
  • mTBI is a leading cause of sustained physical, cognitive, emotional, and behavioral deficits in veterans and the general public.
  • However, the underlying pathophysiology is not completely understood, and there are few effective treatments for post-concussive symptoms (PCS).
  • The study was conducted as a randomized, double-blind, placebo-controlled clinical trial over an eight-week period, with two groups being examined: an active tACS group and a sham tACS group.
  • Mark White, CEO of Nexalin Technology, stated, "We are encouraged by the results of the clinical study, reinforcing the significant reduction in pain and other persistent symptoms of mild traumatic brain injury among veteran patients.

Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results

Retrieved on: 
Wednesday, March 27, 2024
De novo, DFU, Diabetic foot ulcer, Certification, Burn, Government, Development, FY, MDAI, Patient, Research, History, Artificial intelligence, Classification, Sale, Standard of care, Human services, Research and development, Wound healing, Trial of the century, Clinical trial, ASPR, ISO, FDA, Administration, Food, Pharmaceutical industry

DALLAS, March 27, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter (“Q4 2023”) and full year (“FY 2023”) ended December 31, 2023 and provided an update on its ongoing business activities.

Key Points: 
  • DALLAS, March 27, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter (“Q4 2023”) and full year (“FY 2023”) ended December 31, 2023 and provided an update on its ongoing business activities.
  • “Spectral AI achieved much in 2023, and our progress along multiple fronts has continued into 2024,” said Peter M. Carlson, Chief Executive Officer.
  • “
    In September 2023, we were awarded the largest contract in our history from the US Government valued at up to $150.0 million.
  • All comparisons to Q4 2023 and FY 2023 are to the comparable periods ended December 31, 2022, unless otherwise stated.

Manifest MedEx Joins NCQA’s Digital Content Services Early Adopter Program

Retrieved on: 
Tuesday, April 9, 2024
Data Management, Health, Technology, Software, General Health, Networks, HealthNet, Certification, NCQA, CQL, Hospital, HL7, Human services, Elevance Health, Medicaid, Blue Shield, Medicare, CMS

Manifest MedEx, California’s largest nonprofit health data network, announced today it will participate in the NCQA Digital Content Services Early Adopter Program to advance digitized quality measurement initiatives and help shape NCQA’s framework and approach to enabling the practical and flexible use of digital quality measures across the full spectrum of value-based care use cases, including quality reporting for health plans.

Key Points: 
  • Manifest MedEx, California’s largest nonprofit health data network, announced today it will participate in the NCQA Digital Content Services Early Adopter Program to advance digitized quality measurement initiatives and help shape NCQA’s framework and approach to enabling the practical and flexible use of digital quality measures across the full spectrum of value-based care use cases, including quality reporting for health plans.
  • Hosted in Manifest MedEx’s cloud environment, these digital measures take advantage of FHIR® and Clinical Quality Language (CQL), an expression language curated by HL7 that CMS, NCQA, and others have adopted for digital quality measures.
  • “Our participation as a pioneer and Early Adopter of NCQA’s Digital Content Services demonstrates our commitment to advancing digitized quality measurement initiatives to help streamline and reduce costs for HEDIS measure updates and certification and accelerate health care’s transition to a digital measurement ecosystem,” said Jason Buckner, Chief Information Officer, Manifest MedEx.
  • Manifest MedEx has participated in NCQA’s digital quality transformation programs since 2021 when it joined the first cohort of the NCQA Data Aggregator Validation program.

C2Sense® and Princeton BioMeditech Receive Second Award from NIH RADx® Tech High Performance Program for Digitally Connected, At-Home Diagnostic Reader and Multiplex COVID-19/Flu A&B Rapid Test

Retrieved on: 
Tuesday, April 9, 2024
Medical imaging, ACME, Halo, Human services, SARS-CoV-2, NIH, Acceleration, Clinical trial, National Institutes of Health, POC, BBC, Omicron, Biological engineering, Bangladesh Technical Education Board, Federal, Health department, PBM, Princeton University

The companies are currently planning their upcoming clinical trial, regulatory submission, and transfer to manufacture.

Key Points: 
  • The companies are currently planning their upcoming clinical trial, regulatory submission, and transfer to manufacture.
  • "After rigorous testing and intensive data collection, Halo®, used in conjunction with the PBM multiplex rapid test, continues to demonstrate outstanding sensitivity and reliability," said Jason Cox, Ph.D., CEO at C2Sense.
  • "Powered by our latest algorithm release, the price vs. performance of our Halo reader is unparalleled."
  • As always, we remain committed to providing our customers with the best possible solution for at-home testing," added Cox.

Guidehouse Honored with Don Strong Community Partner Award for 2024 by George Washington University Milken Institute School of Public Health

Retrieved on: 
Tuesday, April 9, 2024
Employment, Organization, Public health, Veterans' affairs, Partnership, George Washington University, Public, Knowledge, Food and Drug Administration, University, Human services, Doctor of Philosophy, MD, Student, Bangladesh Technical Education Board, National Institutes of Health, Veritas Capital, Public sector, Medicare, Milken Institute, SPH, Consultant, MHA, Food

WASHINGTON, April 9, 2024 /PRNewswire/ -- Guidehouse , a leading global provider of strategy and managed services to commercial and public sector clients, is proud to announce it has been chosen as the recipient of the Don Strong Community Partner Award for 2024 by the George Washington University Milken Institute School of Public Health (SPH).

Key Points: 
  • WASHINGTON, April 9, 2024 /PRNewswire/ -- Guidehouse , a leading global provider of strategy and managed services to commercial and public sector clients, is proud to announce it has been chosen as the recipient of the Don Strong Community Partner Award for 2024 by the George Washington University Milken Institute School of Public Health (SPH).
  • The Don Strong Community Partner Award is presented to organizations that demonstrate exceptional dedication to advancing public health initiatives and promoting the well-being of communities worldwide.
  • Guidehouse received this prestigious recognition in support of its partnership with the Milken Institute SPH, and steadfast support of the school's mission to educate and train future leaders in public health.
  • Guidehouse was celebrated at the Community Partner Appreciation Event on April 4 at the Milken Institute SPH.

Valeos Welcomes Dr. Stuart Sweet to Board of Directors

Retrieved on: 
Tuesday, April 9, 2024
American Express, Advisory Committee, Transplant, Organ transplantation, St. Louis Children's Hospital, GM, Information technology, Medicine, Entrepreneurship, CPO, Patient, SVP, CISO, Research, Organ, Human services, Doctor of Philosophy, Lung transplantation, MD, Quality of life, Health policy, Former, Hospital, Author, Ecosystem, OPTN, Government, Pediatrics, Dentistry

WASHINGTON, April 9, 2024 /PRNewswire/ -- Valeos, a 501(c)(3) nonprofit organization designed to improve organ transplant outcomes for patients and organ donors through data collaboration, today announced the appointment of Dr. Stuart C. Sweet, MD, PhD to its Board of Directors. Dr. Sweet is the W. McKim Marriott Professor of Pediatrics at Washington University in St. Louis, MO, and served as the 2016-2017 Board President of the Organ Procurement and Transplantation Network (OPTN), the U.S. national transplant system. Dr. Sweet spent more than two decades as the medical director of the pediatric lung transplant program at Washington University School of Medicine in St. Louis and St. Louis Children's Hospital, focusing clinically on pediatric lung transplantation and gaining expertise in organ allocation, clinical outcomes, health policy and the role of information technology in medicine.

Key Points: 
  • "I am honored to join the exceptional team at Valeos and continue my dedication to advancing the U.S. organ transplant system," said Dr. Sweet.
  • "We're excited to welcome Dr. Sweet to our Board of Directors.
  • This announcement follows an exciting year for Valeos, which saw its first appointments to its Board of Directors and Advisory Committee this past January.
  • With the backing of leading figures in healthcare, technology and government, Valeos is committed to building the world's largest de-identified transplant data sandbox.

Medicaid unwinding approaches one-year mark: Disenrolled count surpasses initial expectations, continues to climb

Retrieved on: 
Thursday, March 21, 2024
Family, Federation, Health, COVID-19, Public, Kaiser, Knowledge, Policy, Human services, Health policy, Marketplace, ACA, Health insurance

The U.S. Department of Health & Human Services initially projected up to 15 million people would lose Medicaid or Children’s Health Insurance Program coverage.

Key Points: 
  • The U.S. Department of Health & Human Services initially projected up to 15 million people would lose Medicaid or Children’s Health Insurance Program coverage.
  • Since the beginning of Medicaid unwinding on April 1, 2023, Medicaid has been renewed for almost 40 million beneficiaries.
  • A significant majority of Medicaid disenrollments were procedural disenrollments, meaning enrollees did not complete the required renewal process to keep their Medicaid coverage.
  • As Medicaid unwinding continues, Medicaid enrollees may continue to receive communications and requests from their state or county Medicaid offices requesting information to help determine their Medicaid eligibility.

Inovalon Announces Converged Submissions To Support Health Plan Risk Adjustment Programs

Retrieved on: 
Monday, March 18, 2024
ACA, Algorithm, Software as a service, Health, Risk, Converge, HHS, Human services, Medicare, CMS, Risk management

BOWIE, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of cloud-based software solutions empowering data-driven healthcare, launched Converged Submissions today to simplify and improve encounter data submissions in support of risk adjustment programs.

Key Points: 
  • BOWIE, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of cloud-based software solutions empowering data-driven healthcare, launched Converged Submissions today to simplify and improve encounter data submissions in support of risk adjustment programs.
  • This cloud-based SaaS solution is part of Inovalon's Converged Risk Solution Suite and analyzes encounter data to determine risk adjustment eligibility and deliver complete and accurate encounter data submissions on demand.
  • "Health plans need insights into the complex risk adjustment submissions process and solutions that adhere to CMS regulations.
  • For more information on Converged Submissions, go to inovalon.com/encounter-submissions , and visit Inovalon at RISE National Booth #405 in Nashville, TN.